These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 1531790)

  • 21. [An evaluation of the therapeutic trials aimed at regression of ventricular hypertrophy in arterial hypertension].
    Clémenty J; Dulhoste MN; Bordier P; Lartigue MC; Pons N
    Ann Cardiol Angeiol (Paris); 1991 Oct; 40(8):503-8. PubMed ID: 1836942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Left ventricular remodeling and hypertension. Course with antihypertensive therapy].
    Ollivier JP
    Arch Mal Coeur Vaiss; 1991 Dec; 84 Spec No 4():73-7. PubMed ID: 1838922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk reduction following regression of cardiac hypertrophy.
    Schmieder RE
    Clin Exp Hypertens A; 1990; 12(5):903-16. PubMed ID: 2145097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Left ventricular hypertrophy in hypertensive patients. Ultrasonic and physiopathology: therapeutic implications].
    Herpin D; Raynier P; Ciber M; Amiel A; Boutaud P; Demange J
    Presse Med; 1988 Nov; 17(39):2077-80. PubMed ID: 2974566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regression of left ventricular hypertrophy by medical treatment: present status and possible implications.
    Tarazi RC
    Am J Med; 1983 Sep; 75(3A):80-6. PubMed ID: 6226199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of hypotensive drugs on left ventricular mass and diastolic function].
    Spring A; Haczyński J; Jołda-Mydłowska B; Witkowska M
    Pol Arch Med Wewn; 1995 Jul; 94(1):47-58. PubMed ID: 8524699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Favourable haemodynamic effects of a new multifactorial antihypertensive on left ventricular dimension, wall thickness and function in hypertensive patients.
    Sheiban I; Arosio E; Tonni S; Montresor G; Priante F; Lechi A
    Eur Heart J; 1992 Jun; 13 Suppl A():37-44. PubMed ID: 1356775
    [No Abstract]   [Full Text] [Related]  

  • 28. Regression of cardiac hypertrophy and left ventricular pumping ability postregression.
    Frohlich ED
    J Cardiovasc Pharmacol; 1991; 17 Suppl 2():S81-6. PubMed ID: 1715492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of abnormalities in coronary flow reserve to the pathophysiology of left ventricular hypertrophy secondary to hypertension.
    Marcus ML
    Clin Cardiol; 1989 Dec; 12(12 Suppl 4):IV34-5. PubMed ID: 2533528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of antihypertensive therapy on diastolic dysfunction in left ventricular hypertrophy.
    Betocchi S; Chiariello M
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S116-21. PubMed ID: 1381787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Left ventricular hypertrophy in arterial hypertension].
    Garnier LF; François G; Lang M; Raynaud P; Brochier M
    Presse Med; 1988 Feb; 17(7):333-8. PubMed ID: 2966353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Regression of left ventricular hypertrophy with antihypertensive treatment].
    Galinier M; Bounhoure JP
    Presse Med; 1990 Nov; 19(37):1715-9. PubMed ID: 1979167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Arterial hypertension and arrhythmia].
    Negrusz-Kawecka M
    Wiad Lek; 1992 Apr; 45(7-8):291-4. PubMed ID: 1462591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of left ventricular hypertrophy: chest roentgenography, echocardiography, and electrocardiography.
    Dreslinski GR
    Am J Med; 1983 Sep; 75(3A):47-50. PubMed ID: 6226195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regression of left ventricular hypertrophy in hypertension: comparative effects of three different drugs.
    Mace PJ; Littler WA; Glover DR; Rowlands DB; Stallard TJ
    J Cardiovasc Pharmacol; 1985; 7 Suppl 2():S52-5. PubMed ID: 2409371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left Ventricular Hypertrophy in Hypertensive Athletes can be Reduced by Antihypertensive Medication Despite Continuing Intense Aerobic Exercise.
    Ketelhut S; Franz IW; Ketelhut RG
    High Blood Press Cardiovasc Prev; 2018 Dec; 25(4):385-390. PubMed ID: 30341642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of left ventricular hypertrophy in hypertensive patients.
    Tamargo J; Delpón E; Valenzuela C
    Eur Heart J; 1993 Nov; 14 Suppl J():102-6. PubMed ID: 8281952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of antihypertensive therapy on left ventricular hypertrophy in essential hypertension.
    Frohlich ED
    Adv Nephrol Necker Hosp; 1990; 19():87-100. PubMed ID: 1967894
    [No Abstract]   [Full Text] [Related]  

  • 39. Medical repair of hypertensive left ventricular remodeling.
    Motz WH; Scheler S; Strauer BE
    J Cardiovasc Pharmacol; 1992; 20 Suppl 1():S32-6. PubMed ID: 1380616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Left ventricular hypertrophy: its prime importance as a controllable risk factor.
    Weber JR
    Am Heart J; 1988 Jul; 116(1 Pt 2):272-9. PubMed ID: 2969187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.